Fiche publication
Date publication
novembre 2025
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine
Tous les auteurs :
Quintin K, Josset S, Latorzeff I, Pointreau Y, Biau J, Antoni D, Mesny E
Lien Pubmed
Résumé
We present the updated recommendations of the Société française de radiothérapie oncologique (the French society for radiation oncology) on benign intracranial tumours. Most of them are meningiomas, vestibular schwannomas, pituitary adenomas, craniopharyngiomas, and glomus tumours. Some grow very slowly, and can be observed without specific treatment, especially if they are asymptomatic. Symptomatic or growing tumours are treated by surgery, which is the reference treatment. When surgery is not possible, due to the location of the lesion, or general conditions, radiotherapy can be applied, as it is if there is a postoperative growing residual tumour, or a local relapse. Indications must be discussed at a multidisciplinary panel, with precise evaluation of the benefit and risks of the treatments. The techniques to be used are the most modern ones, as multimodal imaging and image-guided radiation therapy. Stereotactic treatments, using fractionated or single (radiosurgery) doses depending on the size or the location of the tumours, are commonly realized, to avoid as much a possible the occurrence of late side effects.
Mots clés
Adénomes hypophysaires, Benign intracranial tumours, Craniopharyngiomas, Craniopharyngiomes, Guidelines, Meningiomas, Méningiomes, Paragangliomas, Paragangliomes, Pituitary adenomas, Radiotherapy, Radiothérapie, Recommandations, SFRO, Schwannomes vestibulaires, Société française de radiothérapie oncologique, Tumeurs bénignes intracrânienne, Vestibular schwannomas
Référence
Cancer Radiother. 2025 11 21;29(7-8):104775
